Li Yaqiong, Inomata Keiko, Nishihara Eijun, Kakudo Kennichi
Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Department of Clinical and Laboratory Medicine, Yamashita Thyroid Hospital, Fukuoka, Japan.
Gland Surg. 2020 Oct;9(5):1838-1846. doi: 10.21037/gs-20-417.
Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated fibro-inflammatory condition that often causes the formation of tumefactive lesions. The discovery of IgG4-RD linked many well-known isolated conditions as a distinct multi-organ disease, and started an era of promoting investigation and treatment in relevant fields. In the thyroid gland, a subcategory of Hashimoto thyroiditis (HT) with IgG4-rich inflammation was first discovered and named IgG4 thyroiditis by our group. This subtype of HT presents with rapidly progressive clinical manifestations and destructive histopathological features underlying thyroid dysfunction, which are significantly different from the common type of HT. Moreover, other IgG4-rich thyroid conditions in patients with Graves' disease and systemic IgG4-RD have been described. These observations are most frequently reported in the Asian population for unknown reasons. Although recent studies demonstrated that IgG4 thyroiditis is a specific entity independent from IgG4-RD, recognition of this unique subset of thyroid disease has yielded important insights into understanding its pathogenesis and the development of novel therapeutic approaches.
免疫球蛋白G4相关疾病(IgG4-RD)是一种免疫介导的纤维炎症性疾病,常导致瘤样病变的形成。IgG4-RD的发现将许多著名的孤立病症联系在一起,成为一种独特的多器官疾病,并开启了相关领域促进研究和治疗的时代。在甲状腺中,我们团队首次发现了一类伴有IgG4丰富炎症的桥本甲状腺炎(HT)亚型,并将其命名为IgG4甲状腺炎。这种HT亚型表现出快速进展的临床表现以及甲状腺功能障碍潜在的破坏性组织病理学特征,这与常见类型的HT有显著差异。此外,还描述了格雷夫斯病和全身性IgG4-RD患者中其他富含IgG4的甲状腺病症。出于未知原因,这些观察结果在亚洲人群中最为常见。尽管最近的研究表明IgG4甲状腺炎是一种独立于IgG4-RD的特定实体,但对这种独特的甲状腺疾病子集的认识为理解其发病机制和开发新的治疗方法提供了重要见解。